The latest study identifies a hybrid cell population in human breast cancer enriched in senescent cells, and these senescent cells secrete SASPs such as IL-6, which follow WNT-5 pathways and contribute to TNBC chemoresistance and metastatic progression (Fig. 3B).116. This evidence concerns the gene IL6 and breast cancer.